2019 Article 1196
2019 Article 1196
2019 Article 1196
Abstract
Background: Oropharyngeal dysphagia or swallowing difficulties are common in acute care and critical care,
affecting 47% of hospitalised frail elderly, 50% of acute stroke patients and approximately 62% of critically ill
patients who have been intubated and mechanically ventilated for prolonged periods. Complications of dysphagia
include aspiration leading to chest infection and pneumonia, malnutrition, increased length of hospital stay and re-
admission to hospital. To date, most dysphagia interventions in acute care have been tested with acute stroke
populations. While intervention studies in critical care have been emerging since 2015, they are limited and so
there is much to learn about the type, the delivery and the intensity of treatments in this setting to inform future
clinical trials. The aim of this systematic review is to summarise the evidence regarding the relationship between
dysphagia interventions and clinically important patient outcomes in acute and critical care settings.
Methods: We will search MEDLINE, EMBASE, CENTRAL, Web of Science, CINAHL and clinical trial registries from
inception to the present. We will include studies conducted with adults in acute care settings such as acute
hospital wards or units or intensive care units and critical care settings. Studies will be restricted to randomised
controlled trials and quasi-randomised controlled trials comparing a new dysphagia intervention with usual care or
another intervention. The main outcomes that will be collected include length of time taken to return to oral
intake, change in incidence of aspiration and pneumonia, nutritional status, length of hospital stay and quality of
life. Key intervention components such as delivery, intensity, acceptability, fidelity and adverse events associated
with such interventions will be collected to inform future clinical trials. Two independent reviewers will assess
articles for eligibility, data extraction and quality appraisal. A meta-analysis will be conducted as appropriate.
Discussion: No systematic review has attempted to summarise the evidence for oropharyngeal dysphagia
interventions in acute and critical care. Results of the proposed systematic review will inform practice and the
design of future clinical trials.
Systematic review registration: PROSPERO CRD 42018116849 (http://www.crd.york.ac.uk/PROSPERO/)
Keywords: Dysphagia, Deglutition disorders, Acute care, Acute hospital, Critical care, Intensive care, Swallow
interventions, Swallow therapy
* Correspondence: sduncan10@qub.ac.uk
1
Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University, Belfast, 97 Lisburn
Road, Belfast BT9 7BL, UK
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Duncan et al. Systematic Reviews (2019) 8:283 Page 2 of 8
musculature force activation in the expiratory muscles inform future clinical trials of dysphagia
results in improvements in swallow biomechanics, cough interventions in intensive care.
strength and aspiration rates.
Methods
How the intervention might work Types of studies
Swallowing difficulties can arise from both disruptions We will consider intervention studies using randomised
to the central neural swallowing network, as seen in and quasi-randomised clinical trial methodology only.
acute stroke patients, or due to other mechanisms in in- All clinical trials published from inception in any lan-
tensive care causing sensory and motor impairments, guage will be included in this review. Relevant rando-
such as critical illness polyneuropathy. The principle of mised controlled trials are classified as all trials that
neuroplasticity indicates that if a neural substrate is not involve at least one group receiving a specific dysphagia
biologically active, its function can degrade. In swallow- intervention aimed at improving or eliminating dysphagia
ing, disuse of this mechanism may diminish its cortical and one group receiving a traditional dysphagia interven-
representation and pose a threat to functional recovery tion, a placebo or usual care. Treatments administered
in the long term [22]. The aim of direct swallowing re- had to be allocated by a random process. We will classify
habilitation is to accelerate this process of plasticity. as quasi-randomised clinical trials all trials of similar de-
Studies have shown that pushing any muscular system sign where the method of allocation to the treatment
in an intense and persistent way will bring about group is known but is not considered strictly random (i.e.
changes in neural innervation and patterns of movement alternate allocation by day or date of birth or medical rec-
[23]. It is also thought that some dysphagia interventions ord number). We will only include cross-over trials in the
may improve swallowing by enhancing the sensory drive review if the data from the first intervention period were
to the brain and causing increased activity in motor reported and we will only use this data.
swallowing areas [24].
Types of participants
We will include only studies conducted in acute care
Why it is important to do this review? settings (i.e. studies carried out in any acute hospital
The management options for patients with dysphagia in ward or unit including acute medical, respiratory, surgi-
acute care and critical care are limited. This is due his- cal, neurological or critical care/intensive care units
torically to an under recognition of dysphagia and its as- within an acute hospital or tertiary hospital setting).
sociation with increased morbidity and mortality in Adult participants, 18 years or older of any sex, ethni-
these settings. Studies are now emerging in these set- city, stage of illness and degree of medical, respiratory,
tings but are limited, with small sample sizes used and neurological or surgical severity will be included. We
variable results when similar outcomes are addressed will impose no limitations regarding the length of intub-
[13–18, 25]. There is still a lot to learn about interven- ation and ventilation time or the presence of a tracheos-
tion type, mode of delivery and optimal treatment inten- tomy tube in critical care study participants.
sity and timing to ensure effectiveness in intensive care
settings. Often, limited information is provided in stud- Exclusion criteria
ies on protocol adherence and how acceptable an inter- We will exclude cluster-randomised controlled trials as we
vention is for participants and trainers, and so, it is are not considering the group effect of a dysphagia inter-
difficult to know if interventions are genuinely ineffect- vention. We will exclude treatment studies carried out in
ive or have failed to be fully implemented. To date, no outpatient settings, rehabilitation units, residential care
systematic review has looked at both the effectiveness of homes (i.e. nursing homes) or long-term care facilities.
dysphagia interventions in acute and critical care or de-
scribed in detail the key components of interventions Types of interventions
tested in these settings to inform future clinical trials in Interventions
intensive care. We will consider any dysphagia intervention delivered
alone or in combination with a traditional swallowing re-
Objectives habilitation programme (usual care) in included studies.
Such interventions may include:
1. To determine the effectiveness of dysphagia
interventions in improving oral intake and reducing Electrotherapeutic interventions
aspiration for adults in acute and critical care. Respiratory muscle training
2. To identify key intervention components such as Sensory-motor interventions such as thermal-tactile
delivery, dose, intensity, timing and fidelity to stimulation
Duncan et al. Systematic Reviews (2019) 8:283 Page 4 of 8
independently for inclusion or exclusion in the final Any disagreements will be resolved by involving a
study. As before, disagreements will be resolved by dis- third reviewer. We will construct a ‘risk of bias’ table to
cussion and referral to a third author if necessary. present the results within and across studies. We will
use the assessment of risk of bias to perform sensitivity
analyses based on methodological quality as necessary.
Data extraction and management
We will record general study information along with
type of study, the context and organisation of the study Data synthesis and analysis
setting, recruitment information, sample size and patient If sufficient trials are available and their populations and
characteristics (including sex, age, primary diagnosis, co- outcome measures are clinically similar, we will carry
morbidities and severity of dysphagia at baseline). Pri- out meta-analyses of primary and secondary outcomes.
mary and secondary outcomes will be recorded includ- The following measures of treatment effect will be used:
ing the specific measurement, analysis metric, method of risk ratio (RR) and 95% confidence interval (CI) for the
aggregation and time point for each outcome, as per analysis of dichotomous outcomes, mean difference
SPIRIT 2013 statement [33]. A full description of the (MD) or standardised mean differences (SMD) and 95%
intervention including mode of delivery, dose, intensity, CI for continuous outcomes. Individual participants in
timing and fidelity will be extracted using the TIDieR each trial arm will comprise the unit of analysis. We will
checklist [34]. After piloting, this data will be extracted only use data reported from the first intervention time
independently by two authors using a data extraction period in any cross-over trials included in this review.
form (Additional file 2). Any discrepancies will be re- The comparison group will receive either a placebo such
solved by involving a third review author. as sham stimulation or standard care such as traditional
swallowing exercises and/or diet modification.
Assessment of risk of bias If two or more randomised controlled trials contribute
A bias in the conduct of a trial may distort the design, data for an outcome, the data will be combined in a
execution, analysis or interpretation of the research [35]. meta-analysis using Review Manager 5.3 on an intention
In this review, the risk of bias in included studies will be to treat basis if appropriate to do so [37]. We plan to
independently assessed by two review authors using the pool results using RevMan software with a fixed-effect
domain-based evaluation recommended by the Cochrane model and assess the results for heterogeneity. If there is
Collaboration [36]. For each domain, we will assign a substantial heterogeneity, we will repeat the meta-
judgement regarding the risk of bias as ‘high’, ‘low’ or analysis using a random-effects model. Where there are
‘unclear’. The domains include: data from only one study for an outcome, the results will
be reported narratively.
1. Random sequence generation (low risk includes
random methods such as random number table, Assessment of heterogeneity
computer random number generator or coin toss) If the presence of statistical heterogeneity is indicated by
2. Allocation concealment (low risk includes central poor overlap between confidence intervals across stud-
allocation or serially numbered, or sealed, opaque ies, the χ2 (chi-squared) test will be used to measure this
envelopes) statistic. The impact of such heterogeneity on the meta-
3. Blinding of participants and personnel (considered analysis will be evaluated using the I2 statistic. This will
low risk if authors mentioned that participants and describe the percentage of the variability in effect esti-
personnel were blinded to the intervention) mates that is due to differences between trials rather
4. Blinding of outcome assessment (considered low than sampling error (chance). A value of > 50% implies
risk if trial authors mentioned that outcome substantial heterogeneity [38]. We will qualitatively as-
assessors were blinded to group allocation) sess clinical heterogeneity by examining potential
5. Incomplete outcome data (considered low risk if sources, such as the type of intervention in each trial
outcome data were completely addressed) and the type of participants enrolled. Quantitative ex-
6. Selective outcome reporting (considered low risk if ploration of any substantial heterogeneity will also be
a protocol was available and pre-specified outcomes done via subgroup analysis.
were reported accordingly, or in the absence of a
protocol, if all expected outcomes were reported)
7. Other biases such as trial not being registered, Dealing with missing data
interventions being insufficiently well delivered or In the event that data are missing from reported trials,
conflicts of interest such as inappropriate funder we will, where possible, contact trial authors to request
influence access to this data for trials published in the last 5 years.
Duncan et al. Systematic Reviews (2019) 8:283 Page 6 of 8
for Interventional Trials; TIDieR: Template for Intervention Description and endotracheal intubation: a randomized, prospective trial. Crit Care Med.
Replication; UKCTG: United Kingdom Clinical Trials Gateway 2001;29:1710–3.
7. Su H, Hsiaomm T, Ku S, Wang T, Lee J, Tzeng W, Huang G, Chen C. Tongue
Acknowledgements weakness and somatosensory disturbance following oral endotracheal
The author SD would like to thank Mrs. Anamarie Magorrian, Speech and extubation. Dysphagia. 2015;30:188–95.
Language Therapy Assistant Manager, Adult Acute Services, Belfast Health 8. Brodsky M, De I, Chilukuri K, Huang M, Palmer J, Needham D. Coordination
and Social Care Trust, Northern Ireland, for fully supporting all preliminary of pharyngeal and laryngeal swallowing events during single liquid
work completed in clinical settings during pre-doctoral phase and support- swallows after oral endotracheal intubation for patients with acute
ing preparation for doctoral funding application. respiratory distress syndrome. Dysphagia. 2018;33(6):768–77.
9. Puthucheary Z, Rawal J, McPhail M. Acute skeletal muscle wasting in critical
Authors’ contributions illness. J Am Med Assoc. 2013;310(15):1591–600.
SD, BB, DM and MW conceived the idea for the review. SD drafted this 10. Demoule A, Jung B, Prodanovic H. Diaphragm dysfunction on admission to
protocol under the supervision of BB, DM and MW. JMcG commented on the intensive care unit. Prevalence, risk factors and prognostic impact – a
drafts of the protocol. RF assisted SD with the development of a search prospective study. Am J Resp Crit Care Med. 2013;188(2):213–9.
strategy and completion of all electronic database and clinical trial registry 11. Dres M, Dube B, Mayaux J. Coexistence and impact of limb muscle and
searches. All authors read and approved the final manuscript. diaphragm weakness at time of liberation from mechanical ventilation in medical
intensive care unit patients. Am J Resp Crit Care Med. 2017;195(1):57–66.
Authors’ information 12. Speyer R, Baijens L, Heijnen M, Zwijnenberg I. Effects of therapy in
SD is a PhD student at Queen’s University, Belfast (QUB). RF is a medical oropharyngeal dysphagia by speech and language therapists: a systematic
librarian at QUB. JMcG is a lecturer in School of Nursing & Midwifery, QUB. review. Dysphagia. 2010;25(1):40–65.
DMcA and BB are Professors of Critical Care Medicine, QUB. MW is a 13. Beom J, Oh B, Choi K, Kim W, Song YJ, You DS, Kim SJ, Han TR. Effect of
Professor of Clinical Speech and Language Studies at Trinity College Dublin. electrical stimulation of the suprahyoid muscles in brain-injured patients
with dysphagia. Dysphagia. 2015;30:423–9.
14. Kraaijenga S, van der Molen L, Jacobi I, Hamming-Vrieze O, Hilgers FJM, van
Funding
den Breke MWM. Prospective clinical study on long-term swallowing
This work is being conducted as part of a doctoral research fellowship
function and voice quality in advanced head and neck cancer patients
awarded to SD and funded by the Health and Social Care Research and
treated with concurrent chemoradiotherapy and preventive swallowing
Development Division of the Public Health Agency in Northern Ireland, UK.
exercises. Eur Arch Oto Rhino Laryngol. 2015;272(11):3521–31.
15. Ortega O, Rofes L, Martin A, Arreola V, Lopez I, Clave P. A comparative study
Availability of data and materials between two sensory stimulation strategies after two weeks treatment on
Not applicable. older patients with oropharyngeal dysphagia. Dysphagia. 2016;31(5):706–16.
16. Suntrup S, Marian J. Schroder. Electrical pharyngeal stimulation for
Ethics approval and consent to participate dysphagia in tracheostomised stroke patients: a randomised controlled trial.
Not applicable. Inten Care Med. 2015;41(9):1629–37.
17. Brodsky M, Needham D. PReventing the EffectS of Intubation on DEglutition
Consent for publication (PRESIDE). www.clinicaltrials.gov NCT02442102.
Not applicable. 18. Martin AD, Davenport PD, Franceschi AC, Harman E. Use of inspiratory
muscle strength training to facilitate ventilator weaning: a series of 10
Competing interests consecutive patients. Chest. 2002;122:192–6.
The authors declare that they have no competing interests. 19. Martin D, Smith BK, Davenport P, Harman E, Gonzalez-Rothi RJ, Baz M,
Layon J, Banner M, Caruso LJ, Deoghare H, Huang T, Gabrielli A. Inspiratory
Author details muscle strength training improves weaning outcome in failure to wean
1 patients: a randomised trial. Crit Care. 2011;15:R84 http://ccforum.com/
Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University, Belfast, 97 Lisburn content/15/2/R84.
Road, Belfast BT9 7BL, UK. 2School of Nursing and Midwifery, Medical Biology 20. Troche M, Okun M, Rosenbek J, Musson N, Fernandez H, Rodriguez R.
Centre, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Aspiration and swallowing in Parkinson disease and rehabilitation with
3
Queen’s University Belfast Medical Library, Mullhouse Building, Mullhouse EMST. Neurology. 2010;75:1912–9.
Road, Belfast BT12 6DP, UK. 4Department of Clinical Speech and Language 21. Park JS, Oh DH, Chang MY, Kim Troche M, Okun M, Rosenbek J, Musson N,
Studies, Trinity College Dublin, Leinster St. South, Dublin 2 D02 KF66, Ireland. Fernandez H, Rodriguez R. Aspiration and swallowing in Parkinson disease
and rehabilitation with EMST. Neurology. 2010;75:1912–9.
Received: 5 February 2019 Accepted: 13 October 2019 22. Robbins JA, Butler S, Daniels S, Gross RD, Langmore S, Lazarus CL, Martin-
Harris B, McCabe D, Musson N, Rosenbek J. Swallowing and dysphagia
rehabilitation: translating principles of neural plasticity into clinically
References oriented evidence. J Speech Lang Hear Res. 2008;51:276–300.
1. Hamdy S, Aziz Q, Rothwell JC, Power M, Singh KD, Nicolson DA. Recovery of 23. Burkhead L, Sapienza C, Rosenbek JC. Strength-training exercise in
swallowing after dysphagic stroke relates to functional reorganization in the dysphagia rehabilitation: principles, procedures and directions for future
intact motor cortex. Gastroenterology. 1998;115(5):1104–12. research. Dysphagia. 2007;22:251–65.
2. Wirth R, Dziewas R, Beck AM, Clavé P, Hamdy S, Heppner HJ, Langmore S, 24. Hamdy S, Rothwell J, Azizm Q. Long-term reorganisation of human motor
Leischker AH, Martino R, Pluschinski P, Rosler A, Shaker R, Warnecke T, cortex driven by short-term sensory stimulation. Nat Neurosci. 1998;1:64–8.
Sieber C.C, Volkert D. Oropharyngeal dysphagia in older persons – from 25. Hwang C, Choi K, Ko Y. Pre-emptive swallowing stimulation in long-term
pathophysiology to adequate intervention: a review and summary of an intubated patients. Clin Rehabil. 2007;21(1):41–6.
international expert meeting. Clin Interven Aging, 2016; 11: 180-208. 26. Crary M, Carnaby-Mann G, Groher M. Initial psychometric assessment of a
3. Maeda K, Akagi J. Sarcopenia is an independent risk factor of dysphagia in functional oral intake scale for dysphagia in stroke patients. Arch Phys Med
hospitalised older people. Geriatr Gerontolo Int. 2015;16:515–21. Rehabil. 2005;86:1516–20.
4. Muhle P, Wirth R, Glahn J, Dziewas R. Age related changes in swallowing 27. Rosenbek J, Robbins J, Roecker E, Coyle JL, Wood JL. A penetration-
physiology and pathophysiology. Nervenarzt. 2015;86(4):440–51. aspiration scale. Dysphagia. 1996;11:93–8.
5. de Larminat V, Montravers P, Dureuil B, Desmont JM. Alteration in 28. Miles A, Hunting A, McFarlane M, Caddy D. Predictive value of the New
swallowing reflex after extubation in intensive care unit patients. Crit Care Zealand secretion scale for pneumonia. Dysphagia. 2018;33:115–22.
Med. 1995;23(3):486–90. 29. Neubauer PD, Rademaker AW, Leder SB. The Yale Pharyngeal Residue
6. Barquist E, Brown M, Cohn S, Lundy D, Jackowski J. Postextubation Severity Rating Scale: an anatomically defined and image-based tool.
fiberoptic endoscopic evaluation of swallowing after prolonged Dysphagia. 2015;30:521–8.
Duncan et al. Systematic Reviews (2019) 8:283 Page 8 of 8
30. Stratton RJ, King CL, Stroud MA, Jackson AA, Elia M. ‘Malnutrition Universal
Screening Tool’ predicts mortality and length of hospital stay in acutely ill
elderly. Br J Nutr. 2006;95:325–30.
31. McHorney CA, Robbins JA, Lomax K, Rosenbek JK, Chignell K, Kramer AE,
Bricker DE. The SWAL-QOL and SWAL CARE outcomes tool for
oropharyngeal dysphagia in adults: III Documentation of Reliability and
Validity. Dysphagia. 2002;17:97–114.
32. Silbergleit A, Schultz L, Jacobsen B, Beardsley T, Johnson A. The Dysphagia
Handicap Index: Development and Validation. Dysphagia. 2012;27(1):46–52.
33. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K,
Hróbjartsson A, Mann H, Dickersin K, Berlin J, Doré C, Parulekar W,
Summerskill W, Groves T, Schulz K, Sox H, Rockhold FW, Rennie D, Moher D.
SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
Ann Intern Med. 2013;158:200–7.
34. Hoffman T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, Altman D,
Barbour V, Macdonald H, Johnston M, Lamb S, Dixon-Woods M, McCullough
P, Wyatt J, Chan A, Michie S. Better reporting of interventions: template for
intervention description and replication (TIDieR) checklist and guide. BMJ.
2014;348:g1687.
35. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51–63.
36. Higgins, J.P.T., Green, S. (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane
Collab, 2011. Available from www.cochrane-handbook.org.
37. Revman. The Nordic Cochrane Centre, The Cochrane Collaboration. Review
Manager (RevMan) Version 5.3. Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration; 2012.
38. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency
in meta-analyses. Brit Med J. 2003;327(7414):557–60.
39. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected
by a simple, graphical test. BMJ. 1997;315:629–34.
40. Balshem H, Helfand M, Schunemann H, Oxman AD, Kunz R, Brozek J, Vist
GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: rating
the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.
41. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P,
Stewart L, PRISMA-P Group. Preferred reporting items for systematic review
and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
BMJ. 2015;349(jan02 1):g764.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.